Director's Page - National Cancer Institute
Links shared publicly online about this topic.
- 1,027total visits
Director's Page - National Cancer Institute
View full resource at cancer.gov
Tags: Cancer, Health and Human Services
Most Recently Shared on July 12, 2010 at 4:05 pm By:
Harold Varmus was sworn in this morning by HHS Secretary Kathleen Sebelius as the 14th Director of the NCI http://bit.ly/aGzj1g
Despite Physical Challenges, Oregon Family Physician Driven to Succeed -- AAFP News Now -- American Academy of Family Physicians
aafp.org — “Elizabeth Steiner Hayward, M.D., is one amazing woman. At the very least, she’s a woman who does amazing things. Call it a trifecta of accomplishments: First, Steiner Hayward is an associate professor in the Department of Family Medicine at Oregon Health & Science University (OHSU) in Portland, as well as associate director of faculty development for the department. She also serves as director of the Knight Cancer Institute Breast Health Education Program at OHSU and just finished up a ter” View full resource at aafp.org
Most Recently Shared on May 2, 2012 at 11:32 pm By:
Despite Physical Challenges, Oregon Family Physician Driven to Succeed http://t.co/LzpSOjwI
Taste of Country | Roswell Park Cancer Institute
roswellpark.org — “Taste of Country promotional page” View full resource at roswellpark.org
Most Recently Shared on April 11, 2012 at 7:32 pm By:
Country music fans need to check this out! Support breast cancer research & you could win this autographed guitar: http://t.co/CkQBwSyL
Enjoy Every Sandwich « Carolyn Anderson – Motivational Speaker, Entrepreneur & Doctor
feedproxy.google.com — “Enjoy Every Sandwich « Carolyn Anderson – Motivational Speaker, Entrepreneur & Doctor” View full resource at feedproxy.google.com
Most Recently Shared on March 27, 2012 at 1:15 am By:
Pox vaccines extend survival for patients with melanoma, ovarian cancer
medicalxpress.com — “An immunotherapy regimen incorporating poxviruses and targeting a particular tumor antigen, NY-ESO-1, has shown promise in treating two types of cancers. Kunle Odunsi, MD, PhD, Chair of the Department of Gynecologic Oncology and Director of the Center for Immunotherapy at Roswell Park Cancer Institute ...” View full resource at medicalxpress.com
Most Recently Shared on March 26, 2012 at 10:20 pm By:
Pox vaccines extend survival for patients with melanoma, ovarian cancer http://t.co/nohDd8u7
CINJ clinical trials leader receives 2012 Award of Excellence from HOPA
news-medical.net — “Susan Goodin, PharmD, FCCP, BCOP, associate director of clinical trials and therapeutics at The Cancer Institute of New Jersey (CINJ) has received the 2012 Award of Excellence from the Hematology/Oncology Pharmacy Association.” View full resource at news-medical.net
Most Recently Shared on March 22, 2012 at 4:54 pm By:
Oncology News: CINJ clinical trials leader receives 2012 Award of Excellence from HOPA: Susan Goodin, PharmD, FC... http://t.co/lNV58qcn
AACR Welcomes New Members to the Board of Directors and Nominating Committee
aacr.org — “PHILADELPHIA — The members of the American Association for Cancer Research will welcome Charles L. Sawyers, M.D., as president-elect 2012-2013 on Monday, April 2, at the AACR Annual Meeting 2012, held in Chicago, Ill. from March 31 - April 4. Sawyers is chair of the Human Oncology and Pathogenesis Program at Memorial Sloan-Kettering Cancer Center and a Howard Hughes Medical Institute investigator. Additionally, he is a professor in the Cell and Developmental Biology Program and the Departm” View full resource at aacr.org
Most Recently Shared on March 20, 2012 at 6:42 pm By:
AACR Welcomes New Members to the Board of Directors and Nominating Committee: http://t.co/ClVeKy4b via @AddThis
Dr. Guru joins Roswell Park as professor of urologic oncology - - ModernMedicine
modernmedicine.com — “Khurshid Guru, MD, director of the Center for Robotic Surgery at Roswell Park Cancer Institute, Buffalo, NY, has been named the Dr. Robert P. Huben Professor of Urologic Oncology.” View full resource at modernmedicine.com
Most Recently Shared on March 20, 2012 at 1:26 pm By:
Dr. Guru joins Roswell Park as professor of urologic oncology: Khurshid Guru, MD, director of the Center for Rob... http://t.co/qzeVfrLH
Topical imiquimod, staged excisions reduce morbidity in lentigo melanoma - - ModernMedicine
modernmedicine.com — “The treatment of lentigo maligna (LM) with topical imiquimod 5 percent cream followed by conservative staged excisions can significantly reduce surgical morbidity and represents a solution for difficult-to-treat lesions, according to Glen Bowen, M.D., co-director, Multidisciplinary Melanoma Clinic, and associate professor, department of dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City. Dr. Bowen spoke at the 2011 International Melanoma Congress in Tam” View full resource at modernmedicine.com
Most Recently Shared on March 7, 2012 at 9:37 am By:
Topical imiquimod, staged excisions reduce morbidity in lentigo melanoma http://t.co/5cUZRrlP #dermatology
NIH Blueprint for Neuroscience Research: Home Page
neuroscienceblueprint.nih.gov — “The NIH Blueprint for Neuroscience Research is designed to enhance collaboration among the NIH Office of the Director and 15 NIH institutes and centers (ICs) that support research on the nervous system. By pooling resources and expertise and less than one percent of the NIH investment in neuroscience research, the Blueprint confronts challenges that transcend any single institute or center and serves the entire neuroscience community. As a result, best practices developed at a single IC are impl” View full resource at neuroscienceblueprint.nih.gov
Most Recently Shared on March 1, 2012 at 4:35 pm By:
NIH Blueprint for Neuroscience Research: Home Page http://t.co/GVb6aGw4
Study identifies USP15 as a critical protein in cancer
news-medical.net — “After years studying the molecular bases of glioblastoma - the most common brain tumor and one of the most aggressive of all cancers, the group led by Dr. Joan Seoane , Director of Translational Research at the Vall d'Hebron Institute of Oncology (VHIO) and ICREA Research Professor has today published a study in Nature Medicine identifying USP15 as a critical protein in cancer which, thanks to its molecular characteristics, shows enormous therapeutic promise.” View full resource at news-medical.net
Most Recently Shared on February 20, 2012 at 7:57 am By:
Oncology News: Study identifies USP15 as a critical protein in cancer: After years studying the molecular bases ... http://t.co/JdJ8Jz6t
EntreMed announces $10 million in financing from strategic accredited investors
news-medical.net — “EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has secured $10 million in financing with strategic accredited investors, including IDG-Accel China Growth Fund II L.P., Emerging Technology Partners, LLC, and Dr. Tak W. Mak, Director of The Campbell Family Institute for Cancer Research.” View full resource at news-medical.net
Most Recently Shared on January 23, 2012 at 4:12 pm By:
EntreMed announces $10 million in financing from strategic accredited investors: EntreMed, Inc., a clinical-stag... http://t.co/uMGFf2zC
Penn's cancer institute is suing a former top aide and his firm in the theft of intellectual property | Philadelphia Inquirer | 01/13/2012
philly.com — “The University of Pennsylvania's cancer research institute is suing its former scientific director and a biotechnology company he founded for more than $1 billion, accusing him of stealing intellectual property and trying to profit from it.” View full resource at philly.com
Most Recently Shared on January 13, 2012 at 12:54 pm By:
Penn's cancer institute is suing a former top aide and his firm in the theft of intellectual property http://t.co/b1fmcHzr
Symposier - Dr. Belani Discusses NSCLC Adjuvant Therapy
symposier.com — “Uploaded and shared in Youtube by: OncLiveTV — Chandra P. Belani, MD, Deputy Director, Penn State Hershey Cancer Institute, Miriam Beckner Distinguished Professor of Medicine, Penn State Hershey Medical Center & College of Medicine, discusses recent changes to adjuvant therapy for non-small cell lung cancer (NSCLC). Adjuvant therapy is the current standard of care for patients with resectable NSCLC. Various trials have suggested that the absolute improvement in overall survival from adjuvant tre” View full resource at symposier.com
Most Recently Shared on January 4, 2012 at 5:56 pm By:
Recent changes to adjuvant therapy for non-small cell lung cancer (NSCLC). http://t.co/maBnxPAJ
TGen's Trent to lead international skin cancer study - Phoenix Business Journal
bizjournals.com — “Dr. Jeff Trent, president and research director at the Translational Genomics Research...” View full resource at bizjournals.com
Most Recently Shared on December 14, 2011 at 4:57 pm By:
Jeff Trent, Translational Genomics Research Institute is principal investigator on a $6M study of deadly skin cancer. http://t.co/KpegBNeY
We Give Cancer to Ourselves - Video - iHealthTube.com
ihealthtube.com — “How do we get cancer? It's one of the biggest health questions people face. Bob Wright, director of the American Anti-Cancer Institute, says the answer is simple. He says there are a couple of simple reasons why people get cancer.” View full resource at ihealthtube.com
Most Recently Shared on December 7, 2011 at 1:40 am By:
We Give Cancer to Ourselves - Video - http://t.co/5f8i4HLz http://t.co/PTRXYXii
Advertisement

